← Open Payments lookup

MARY DAMERON: Open Payments

NPI 1467426254 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,635 in 26 payments from 13 companies in 2025. Trend: 2023 $2,700 · 2024 $1,397 · 2025 $1,635

Food & beverage: $1,635
CompanyPaymentsAmount
Axsome Therapeutics, Inc.2$247
Amgen Inc.2$205
ABBVIE INC.8$192
Supernus Pharmaceuticals, Inc.4$159
E.R. Squibb & Sons, L.L.C.1$135
Dexcom, Inc.1$115
Daiichi Sankyo Inc.1$108
Teva Pharmaceuticals USA, Inc.1$103
Phathom Pharmaceuticals, Inc.1$97
Neurocrine BioSciences, Inc.1$83

Products named: Auvelity, VRAYLAR, Qelbree, COBENFY, DEXCOM G7 GSS (161), INJECTAFER, REPATHA, AUSTEDO XR.

Industry payments across MD — which companies pay providers there.